对KRAS相互作用蛋白的因子导向识别
Sanan Wu1,2, Xiaoyang Gao1,2, Di Wu1,2
1Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
BMC biology
|November 20, 2024
概括
研究人员开发了一种新的工作流程,以识别KRAS相互作用的蛋白质,这对于理解癌症和开发新疗法至关重要. 这种方法成功地预测并验证了GRB10作为一个新的KRAS绑定合作伙伴.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 在癌症药物发现中,KRAS是一个重要的但具有挑战性的目标.
- 克拉斯通过蛋白质与蛋白质相互作用调节癌症的进展,许多合作伙伴尚未确定.
研究的目的:
- 开发和验证用于预测新型KRAS相互作用蛋白的计算工作流.
- 通过了解KRAS驱动的瘤机制来确定新的治疗点.
主要方法:
- 在人类蛋白质数据库中使用17个KRAS交互动图案作为基于结构的相似性搜索的查询.
- 使用内部预测方法PPI-Miner来识别潜在的KRAS交互器.
- 使用生物层干涉计,免疫光和共免疫沉进行实验验证的预测.
主要成果:
- 预测了78个潜在的KRAS相互作用蛋白;10个被选择用于验证.
- 确定了4种具有与KRAS结合亲和力的蛋白质,包括GRB10.
- 使用生物化学和细胞分析证实了GRB10 (RA-PH域) 与KRAS的相互作用.
结论:
- 开发的工作流有效地预测了与KRAS相互作用的蛋白质.
- 这些发现提高了对KRAS驱动的癌症的理解,并为治疗策略的制定提供了信息.
相关概念视频
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K


